Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 1378-1383, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Umapathysivam, K.
Right arrow Articles by Meikle, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Umapathysivam, K.
Right arrow Articles by Meikle, P. J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2001;47:1378-1383.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Determination of Acid {alpha}-Glucosidase Activity in Blood Spots as a Diagnostic Test for Pompe Disease

Kandiah Umapathysivam1, John J. Hopwood1 and Peter J. Meikle1a

1 Lysosomal Diseases Research Unit, Department of Chemical Pathology, Women’s and Children’s Hospital, 72 King William Rd., North Adelaide, South Australia 5006, Australia.

aAuthor for correspondence. Fax 61-8-8204-7100; e-mail peter.meikle{at}adelaide.edu.au.

Background: Pompe disease is an autosomal recessive disorder of glycogen metabolism that is characterized by a deficiency of the lysosomal acid {alpha}-glucosidase. Enzyme replacement therapy for the infantile and juvenile forms of Pompe disease currently is undergoing clinical trials. Early diagnosis before the onset of irreversible pathology is thought to be critical for maximum efficacy of current and proposed therapies. In the absence of a family history, the presymptomatic detection of these disorders ideally can be achieved through a newborn-screening program. Currently, the clinical diagnosis of Pompe disease is confirmed by the virtual absence, in infantile onset, or a marked reduction, in juvenile and adult onset, of acid {alpha}-glucosidase activity in muscle biopsies and cultured fibroblasts. These assays are invasive and not suited to large-scale screening.

Methods: A sensitive immune-capture enzyme activity assay for the measurement of acid {alpha}-glucosidase protein was developed and used to determine the activity of this enzyme in dried-blood spots from newborn and adult controls, Pompe-affected individuals, and obligate heterozygotes.

Results: Pompe-affected individuals showed an almost total absence of acid {alpha}-glucosidase activity in blood spots. The assay showed a sensitivity and specificity of 100% for the identification of Pompe-affected individuals.

Conclusions: The determination of acid {alpha}-glucosidase activity in dried-blood spots is a useful, noninvasive diagnostic assay for the identification of Pompe disease. With further validation, this procedure could be adapted for use with blood spots collected in newborn-screening programs.




The following articles in journals at HighWire Press have cited this article:


Home page
PediatricsHome page
O. Staretz-Chacham, T. C. Lang, M. E. LaMarca, D. Krasnewich, and E. Sidransky
Lysosomal Storage Disorders in the Newborn
Pediatrics, April 1, 2009; 123(4): 1191 - 1207.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Bembi, E. Cerini, C. Danesino, M. A. Donati, S. Gasperini, L. Morandi, O. Musumeci, G. Parenti, S. Ravaglia, F. Seidita, et al.
Diagnosis of glycogenosis type II
Neurology, December 2, 2008; 71(23_suppl_2): S4 - S11.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Mohd. A. F. Tan, C. J. Dean, J. J. Hopwood, and P. J. Meikle
Diagnosis of Metachromatic Leukodystrophy by Immune Quantification of Arylsulphatase A Protein and Activity in Dried Blood Spots
Clin. Chem., November 1, 2008; 54(11): 1925 - 1927.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Parkinson-Lawrence, M. Fuller, J. J. Hopwood, P. J. Meikle, and D. A. Brooks
Immunochemistry of Lysosomal Storage Disorders
Clin. Chem., September 1, 2006; 52(9): 1660 - 1668.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. J. Dean, M. R. Bockmann, J. J. Hopwood, D. A. Brooks, and P. J. Meikle
Detection of Mucopolysaccharidosis Type II by Measurement of Iduronate-2-Sulfatase in Dried Blood Spots and Plasma Samples
Clin. Chem., April 1, 2006; 52(4): 643 - 649.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. S. Millington
Newborn Screening for Lysosomal Storage Disorders
Clin. Chem., May 1, 2005; 51(5): 808 - 809.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Wang, B. Eadala, M. Sadilek, N. A. Chamoles, F. Turecek, C. R. Scott, and M. H. Gelb
Tandem Mass Spectrometric Analysis of Dried Blood Spots for Screening of Mucopolysaccharidosis I in Newborns
Clin. Chem., May 1, 2005; 51(5): 898 - 900.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Fuller, M. Lovejoy, D. A. Brooks, M. L. Harkin, J. J. Hopwood, and P. J. Meikle
Immunoquantification of {alpha}-Galactosidase: Evaluation for the Diagnosis of Fabry Disease
Clin. Chem., November 1, 2004; 50(11): 1979 - 1985.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. J. Meikle, E. Ranieri, H. Simonsen, T. Rozaklis, S. L. Ramsay, P. D. Whitfield, M. Fuller, E. Christensen, F. Skovby, and J. J. Hopwood
Newborn Screening for Lysosomal Storage Disorders: Clinical Evaluation of a Two-Tier Strategy
Pediatrics, October 1, 2004; 114(4): 909 - 916.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Li, C. R. Scott, N. A. Chamoles, A. Ghavami, B. M. Pinto, F. Turecek, and M. H. Gelb
Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening
Clin. Chem., October 1, 2004; 50(10): 1785 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Li, K. Brockmann, F. Turecek, C. R. Scott, and M. H. Gelb
Tandem Mass Spectrometry for the Direct Assay of Enzymes in Dried Blood Spots: Application to Newborn Screening for Krabbe Disease
Clin. Chem., March 1, 2004; 50(3): 638 - 640.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado
Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine
Clin. Chem., March 1, 2004; 50(3): 530 - 536.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. W. Lam, Y. P. Yuen, K. Y. Chan, S. F. Tong, C. K. Lai, T. C. Chow, K. C. Lee, Y. W. Chan, and F. Martiniuk
Juvenile-onset glycogen storage disease type II with novel mutations in acid {alpha}-glucosidase gene
Neurology, February 25, 2003; 60(4): 715 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Yan, N. Raben, and P. Plotz
The Human Acid alpha -Glucosidase Gene Is a Novel Target of the Notch-1/Hes-1 Signaling Pathway
J. Biol. Chem., August 9, 2002; 277(33): 29760 - 29764.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Rozaklis, S. L. Ramsay, P. D. Whitfield, E. Ranieri, J. J. Hopwood, and P. J. Meikle
Determination of Oligosaccharides in Pompe Disease by Electrospray Ionization Tandem Mass Spectrometry
Clin. Chem., January 1, 2002; 48(1): 131 - 139.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.